Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FATE

Fate Therapeutics Inc

Jun 10 • 03:01PM ET

1.89

-0.00 -0.26 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: IWM VTI IWN VXF SCHA VTWO IWC PRFZ VHT DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	5.17%	Shs Outstand	116.27M	Perf Week	-14.64%
Market Cap	220.88M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	-1.15%	Shs Float	110.53M	Perf Month	-13.07%
Enterprise Value	122.84M	PEG	-	EPS next Q	-0.27	Inst Own	60.84%	Short Float	9.68%	Perf Quarter	54.07%
Income	-129.91M	P/S	34.95	EPS this Y	6.40%	Inst Trans	11.30%	Short Ratio	3.84	Perf Half Y	77.10%
Sales	6.32M	P/B	1.23	EPS next Y	9.70%	ROA	-38.01%	Short Interest	10.70M	Perf YTD	92.86%
Book/sh	1.55	P/C	1.26	EPS next 5Y	5.01%	ROE	-55.50%	52W High	2.88 -34.20%	Perf Year	13.47%
Cash/sh	1.50	P/FCF	-	EPS past 3/5Y	26.67% 11.42%	ROIC	-51.60%	52W Low	0.91 108.24%	Perf 3Y	-61.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-58.98% -26.71%	Gross Margin	-97.69%	Volatility	11.90% 12.68%	Perf 5Y	-97.86%
Dividend TTM	-	EV/Sales	19.44	EPS Y/Y TTM	26.97%	Oper. Margin	-2207.47%	ATR (14)	0.23	Perf 10Y	14.85%
Dividend Ex-Date	-	Quick Ratio	5.85	Sales Y/Y TTM	-52.64%	Profit Margin	-2056.79%	RSI (14)	45.19	Recom	1.91
Dividend Gr. 3/5Y	- -	Current Ratio	5.85	EPS Q/Q	18.19%	SMA20	-11.89%	Beta	2.59	Target Price	5.41
Payout	-	Debt/Eq	0.43	Sales Q/Q	-20.26%	SMA50	7.07%	Rel Volume	0.50	Prev Close	1.90
Employees	161	LT Debt/Eq	0.40	Earnings	May 13 BMO	SMA200	43.11%	Avg Volume	2.79M	Price	1.89
IPO	Oct 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.14% -12.93%	Trades		Volume	1,198,145	Change	-0.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)